img

Global Immune Cell Therapy Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Immune Cell Therapy Market Research Report 2024

Immune Cell Therapy is a medical treatment approach that involves modifying a patient's own immune cells, typically T cells, to enhance their ability to recognize and attack cancer cells or other diseases.
According to MRA Research’s new survey, global Immune Cell Therapy market is projected to reach US$ 15060 million in 2033, increasing from US$ 3435 million in 2023, with the CAGR of 23.7% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Immune Cell Therapy market research.
The global pharmaceutical market is 1475 billion USD in 2023, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2023. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2023. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Immune Cell Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
Segment by Type
T Cell Therapy
Natural Killer (NK) Cell Therapy
Other

Segment by Application


Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophageal Cancer
Pancreatic Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Immune Cell Therapy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune Cell Therapy Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 T Cell Therapy
1.2.3 Natural Killer (NK) Cell Therapy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Immune Cell Therapy Market Growth by Application: 2018 VS 2023 VS 2033
1.3.2 Stomach Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophageal Cancer
1.3.6 Pancreatic Cancer
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immune Cell Therapy Market Perspective (2018-2033)
2.2 Immune Cell Therapy Growth Trends by Region
2.2.1 Global Immune Cell Therapy Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Immune Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Immune Cell Therapy Forecasted Market Size by Region (2024-2033)
2.3 Immune Cell Therapy Market Dynamics
2.3.1 Immune Cell Therapy Industry Trends
2.3.2 Immune Cell Therapy Market Drivers
2.3.3 Immune Cell Therapy Market Challenges
2.3.4 Immune Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune Cell Therapy Players by Revenue
3.1.1 Global Top Immune Cell Therapy Players by Revenue (2018-2023)
3.1.2 Global Immune Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Immune Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immune Cell Therapy Revenue
3.4 Global Immune Cell Therapy Market Concentration Ratio
3.4.1 Global Immune Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune Cell Therapy Revenue in 2023
3.5 Immune Cell Therapy Key Players Head office and Area Served
3.6 Key Players Immune Cell Therapy Product Solution and Service
3.7 Date of Enter into Immune Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune Cell Therapy Breakdown Data by Type
4.1 Global Immune Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Immune Cell Therapy Forecasted Market Size by Type (2024-2033)
5 Immune Cell Therapy Breakdown Data by Application
5.1 Global Immune Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Immune Cell Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Immune Cell Therapy Market Size (2018-2033)
6.2 North America Immune Cell Therapy Market Growth Rate by Country: 2018 VS 2023 VS 2033
6.3 North America Immune Cell Therapy Market Size by Country (2018-2023)
6.4 North America Immune Cell Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immune Cell Therapy Market Size (2018-2033)
7.2 Europe Immune Cell Therapy Market Growth Rate by Country: 2018 VS 2023 VS 2033
7.3 Europe Immune Cell Therapy Market Size by Country (2018-2023)
7.4 Europe Immune Cell Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immune Cell Therapy Market Size (2018-2033)
8.2 Asia-Pacific Immune Cell Therapy Market Growth Rate by Region: 2018 VS 2023 VS 2033
8.3 Asia-Pacific Immune Cell Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Immune Cell Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immune Cell Therapy Market Size (2018-2033)
9.2 Latin America Immune Cell Therapy Market Growth Rate by Country: 2018 VS 2023 VS 2033
9.3 Latin America Immune Cell Therapy Market Size by Country (2018-2023)
9.4 Latin America Immune Cell Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune Cell Therapy Market Size (2018-2033)
10.2 Middle East & Africa Immune Cell Therapy Market Growth Rate by Country: 2018 VS 2023 VS 2033
10.3 Middle East & Africa Immune Cell Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Immune Cell Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Detail
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune Immune Cell Therapy Introduction
11.1.4 Adaptimmune Revenue in Immune Cell Therapy Business (2018-2023)
11.1.5 Adaptimmune Recent Development
11.2 Altor Bioscience Corporation
11.2.1 Altor Bioscience Corporation Company Detail
11.2.2 Altor Bioscience Corporation Business Overview
11.2.3 Altor Bioscience Corporation Immune Cell Therapy Introduction
11.2.4 Altor Bioscience Corporation Revenue in Immune Cell Therapy Business (2018-2023)
11.2.5 Altor Bioscience Corporation Recent Development
11.3 Cellectis
11.3.1 Cellectis Company Detail
11.3.2 Cellectis Business Overview
11.3.3 Cellectis Immune Cell Therapy Introduction
11.3.4 Cellectis Revenue in Immune Cell Therapy Business (2018-2023)
11.3.5 Cellectis Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Detail
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics Immune Cell Therapy Introduction
11.4.4 Juno Therapeutics Revenue in Immune Cell Therapy Business (2018-2023)
11.4.5 Juno Therapeutics Recent Development
11.5 Kite Pharma
11.5.1 Kite Pharma Company Detail
11.5.2 Kite Pharma Business Overview
11.5.3 Kite Pharma Immune Cell Therapy Introduction
11.5.4 Kite Pharma Revenue in Immune Cell Therapy Business (2018-2023)
11.5.5 Kite Pharma Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Immune Cell Therapy Introduction
11.6.4 Novartis Revenue in Immune Cell Therapy Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Detail
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Immune Cell Therapy Introduction
11.7.4 Takara Bio Revenue in Immune Cell Therapy Business (2018-2023)
11.7.5 Takara Bio Recent Development
11.8 Unum Therapeutics
11.8.1 Unum Therapeutics Company Detail
11.8.2 Unum Therapeutics Business Overview
11.8.3 Unum Therapeutics Immune Cell Therapy Introduction
11.8.4 Unum Therapeutics Revenue in Immune Cell Therapy Business (2018-2023)
11.8.5 Unum Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immune Cell Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2033
Table 2. Key Players of T Cell Therapy
Table 3. Key Players of Natural Killer (NK) Cell Therapy
Table 4. Key Players of Other
Table 5. Global Immune Cell Therapy Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2033
Table 6. Global Immune Cell Therapy Market Size by Region (US$ Million): 2018 VS 2023 VS 2033
Table 7. Global Immune Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Immune Cell Therapy Market Share by Region (2018-2023)
Table 9. Global Immune Cell Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Immune Cell Therapy Market Share by Region (2024-2033)
Table 11. Immune Cell Therapy Market Trends
Table 12. Immune Cell Therapy Market Drivers
Table 13. Immune Cell Therapy Market Challenges
Table 14. Immune Cell Therapy Market Restraints
Table 15. Global Immune Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Immune Cell Therapy Market Share by Players (2018-2023)
Table 17. Global Top Immune Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy as of 2023)
Table 18. Ranking of Global Top Immune Cell Therapy Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Immune Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Immune Cell Therapy Product Solution and Service
Table 22. Date of Enter into Immune Cell Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immune Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Immune Cell Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global Immune Cell Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Immune Cell Therapy Revenue Market Share by Type (2024-2033)
Table 28. Global Immune Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Immune Cell Therapy Revenue Market Share by Application (2018-2023)
Table 30. Global Immune Cell Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Immune Cell Therapy Revenue Market Share by Application (2024-2033)
Table 32. North America Immune Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 33. North America Immune Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Immune Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Immune Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 36. Europe Immune Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Immune Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Immune Cell Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2023 VS 2033
Table 39. Asia-Pacific Immune Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Immune Cell Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Immune Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 42. Latin America Immune Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Immune Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Immune Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 45. Middle East & Africa Immune Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Immune Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 47. Adaptimmune Company Detail
Table 48. Adaptimmune Business Overview
Table 49. Adaptimmune Immune Cell Therapy Product
Table 50. Adaptimmune Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 51. Adaptimmune Recent Development
Table 52. Altor Bioscience Corporation Company Detail
Table 53. Altor Bioscience Corporation Business Overview
Table 54. Altor Bioscience Corporation Immune Cell Therapy Product
Table 55. Altor Bioscience Corporation Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 56. Altor Bioscience Corporation Recent Development
Table 57. Cellectis Company Detail
Table 58. Cellectis Business Overview
Table 59. Cellectis Immune Cell Therapy Product
Table 60. Cellectis Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 61. Cellectis Recent Development
Table 62. Juno Therapeutics Company Detail
Table 63. Juno Therapeutics Business Overview
Table 64. Juno Therapeutics Immune Cell Therapy Product
Table 65. Juno Therapeutics Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 66. Juno Therapeutics Recent Development
Table 67. Kite Pharma Company Detail
Table 68. Kite Pharma Business Overview
Table 69. Kite Pharma Immune Cell Therapy Product
Table 70. Kite Pharma Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 71. Kite Pharma Recent Development
Table 72. Novartis Company Detail
Table 73. Novartis Business Overview
Table 74. Novartis Immune Cell Therapy Product
Table 75. Novartis Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Takara Bio Company Detail
Table 78. Takara Bio Business Overview
Table 79. Takara Bio Immune Cell Therapy Product
Table 80. Takara Bio Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 81. Takara Bio Recent Development
Table 82. Unum Therapeutics Company Detail
Table 83. Unum Therapeutics Business Overview
Table 84. Unum Therapeutics Immune Cell Therapy Product
Table 85. Unum Therapeutics Revenue in Immune Cell Therapy Business (2018-2023) & (US$ Million)
Table 86. Unum Therapeutics Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune Cell Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Immune Cell Therapy Market Share by Type: 2023 VS 2033
Figure 3. T Cell Therapy Features
Figure 4. Natural Killer (NK) Cell Therapy Features
Figure 5. Other Features
Figure 6. Global Immune Cell Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Immune Cell Therapy Market Share by Application: 2023 VS 2033
Figure 8. Stomach Cancer Case Studies
Figure 9. Lung Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Esophageal Cancer Case Studies
Figure 12. Pancreatic Cancer Case Studies
Figure 13. Other Case Studies
Figure 14. Immune Cell Therapy Report Years Considered
Figure 15. Global Immune Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Immune Cell Therapy Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 17. Global Immune Cell Therapy Market Share by Region: 2023 VS 2033
Figure 18. Global Immune Cell Therapy Market Share by Players in 2023
Figure 19. Global Top Immune Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Immune Cell Therapy Revenue in 2023
Figure 21. North America Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Immune Cell Therapy Market Share by Country (2018-2033)
Figure 23. United States Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Immune Cell Therapy Market Share by Country (2018-2033)
Figure 27. Germany Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Immune Cell Therapy Market Share by Region (2018-2033)
Figure 35. China Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Immune Cell Therapy Market Share by Country (2018-2033)
Figure 43. Mexico Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Immune Cell Therapy Market Share by Country (2018-2033)
Figure 47. Turkey Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Immune Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Adaptimmune Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 50. Altor Bioscience Corporation Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 51. Cellectis Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 52. Juno Therapeutics Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 53. Kite Pharma Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 54. Novartis Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 55. Takara Bio Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 56. Unum Therapeutics Revenue Growth Rate in Immune Cell Therapy Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed